Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin prolonged-release tablets for primary insomnia in older adults
CTR20140245Phase 2Active
- Sponsor
- Chengdu Dawei Pharmaceutical Technology
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in primary insomnia, sponsored by Chengdu Dawei Pharmaceutical Technology. Started Apr 2014; status: active.
02
Drugs
melatonin
03
Conditions
primary insomnia
Beyond the preview
Go deeper on CTR20140245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140245.